Our team of experienced managers and business entrepreneurs are prepared for the challenge of advancing the medical applications and benefits of radionuclide therapy by providing solutions to supply problems and solving related safety issues in processing and using these radioisotopes.

The Company's management has extensive experience in the medical business and radiochemistry expertise that creates a unique opportunity for NorthStar Nuclear Medicine. 

Contact Information

Corporate Headquarters:

NorthStar Nuclear Medicine, LLC

706 Williamson St.

Madison,  WI  53703

Ph:  (608) 316-6980

Fax:  (608) 316-6981

NorthStar Nuclear Medicine is also establishing a Scientific Board of Advisors which will advise and assist management in strategic direction and planning for new and existing uses of radioisotopes.  Any interest in participating or serving on this valuable company asset can be directed to the Chairman, James T. Harvey.  His email is jharvey@northstarnm.com.

Company Management

George P. Messina, Chairman and CEO

Mr. Messina has more than thirty (30) years of managerial experience where in the past twenty (20) years has included the roles of Chief Operating Officer and since 1992 as a President and CEO.   Mr. Messina has developed and executed strategic plans which included funding all of his business' M&A activity which involved identification, acquisition and assimilation those acquisitions.  He also acquired and developed core technologies, involving complex license agreements, to establish a strong competitive technical advantage.  He has raised equity, debt and mezzanine financing, restructured trade or bank debt to avoid bankruptcy, restructured company cost structure, identified and closed on strategic acquisitions, funding of those acquisitions, acquiring new technologies, developing world-wide distribution channels, and guided the sale of companies.   In addition he has forged relationships with universities domestically and abroad in the continued development and commercialization of technologies developed in the university environment.  His international experience also has included the founding of a joint venture in Shanghai, PRC, for the manufacture and distribution of medical device products throughout the Far East for Burdick.  Mr. Messina received his BSEE in 1972 from New Jersey Institute of Technology and has completed study towards his MBA at Western New England College, Wilbraham, Massachusetts. [email: gmessina@northstarnm.com]

Glenn H. Isensee, Senior Vice President and Chief Technology Officer

Mr. Isensee has twenty-four (24) years of design and managerial experience in the areas of scientific and medical instrumentation, including the role of Vice President of Technology for a major player in the medical device arena.  During his career, responsibilities have included analog and digital design, project management, multi-discipline product design (industrial, electrical, mechanical, and software engineering), engineering research, manufacturing engineering, and quality assurance.   Mr. Isensee brings a unique management talent and understanding to the importance of "time to market" and "window of opportunity" and how risk management is a key to successful introduction of new technologies - all while meeting development costs and business cost-of-goods-sold goals.  He has been responsible and managed efforts involving the Food and Drug Association, ISO-9000 and the European Union’s Medical Device Directive. His ability to strategically utilize technology expertise and managerial skill for a business advantage is a unique strength.  Mr. Isensee received an A.S. degree in Biomedical Electronics in 1976 and a BSEE in 1980 from the University of Wisconsin - Madison. [email: gisensee@northstarnm.com]

Michael M. Caponetto, Senior Vice President, Chief Financial Officer

Mr. Caponetto is responsible for all corporate financial, treasury, planning, analysis, accounting, Human Resource and administration activities in addition to helping drive strategic development for the Company.   He brings over 15 years of financial and management experience in finance with corporate and investment banking.  Mr. Caponetto received a Masters of Business Administration with concentrations in Finance and Accounting from the University of Chicago Graduate School of Business and a Bachelor of Arts degree in Economics from the University of Redlands, Redlands, CA.  [email: mcaponetto@northstarnm.com]

James F. Cooper, PharmD, Vice President, Quality Assurance and Regulatory Affairs

Dr. Cooper has over 40 years of career experience with the U.S. Public Health Service, a consultant to the United States Food and Drug Administration, teaching at major medical universities,  and founding a company based on his own personal research.  He has actively consulted for medical companies in the areas of  hemodialysis water systems, depyrogenation, endotoxin testing, development of  analytical test methods, quality systems and CGMP for the production of radiopharmaceuticals.  His assignments while employed by the Public Health Service included hospital pharmacy, Director of I-V services at the Bureau of Radiological Health and the Food and Drug Association in Rockville, MD and a Nuclear Medicine Liaison Officer for the FDA.  He has actively taught at major medical institutions as an Associate Professor of Pharmacy with joint appointments in the Department of Medicine and Pharmacy.  He has taught radiological sciences to physicians, undergraduate and graduate pharmacy students and other health professionals.  His research into a more reliable test for potent bacterial endotoxins led to a discovery of a new method and testing standard used by the FDA and health sciences.

Dr. Cooper has been appointed a committee member of the United States Pharmacopoeia Council of Experts Sterile Compounding Committee  2005-2010.  His publications  have appeared in several past and recent textbooks, specializing in the area of Microbial Contamination Control in Parenteral manufacturing, Laboratory Validation, Microbiology in Pharmaceutical Manufacturing, Encyclopedia of Pharmaceutical Technology and Pyrogen and Sterility Testing of Radiopharmaceuticals.  He remains active in journal publications and is an industry consultant for both the FDA and pharmaceutical industries. 

Dr. Cooper remains involved with teaching at the University of Tennessee Health Science Center, Memphis and serves on the faculty for Parenteral Drug Association (PDA) Training and Research Institute for Aseptic Processing.  He has received awards for scientific achievement from the American Pharmacists Association (2003), an Academy Fellow from the Academy of Pharmacy Practice and Management (1987), and a Nuclear Pharmacy Pioneer from the American Pharmacists Association.  Dr. Cooper received his Doctor of Pharmacy in 1974 from the University of Tennessee College of Pharmacy, a M.S. in Radiological Sciences in 1970 form Johns Hopkins University School of Hygiene and Public Health, and undergraduate degree in chemistry from Wheaton College. [email: jcooper@northstarnm.com]

James T. Harvey, Ph.D.  Vice President and Chief Science Officer

Dr. Harvey has over twenty (28) years of design and operational management experience in the area of scientific development and business operations.  During his career, he either invented or was a co-inventor of several issued patented technologies.  His operational responsibilities have included management of various laboratory operations in the nuclear and mixed waste operations support and environmental services.  While involved in technology start-up companies, he was responsible for manufacturing, developed quality assurance programs for compliance to Nuclear Regulatory Commission and Department of Energy requirements, managed company activities to ensure compliance with federal and state regulations, and managed major government contracts involving federal research and development contracts.  He has extensive experience in laboratory facility planning and build-out.  Dr. Harvey received a B.S. degree in Chemistry in 1971 from the University of Virginia and a Ph.D. in Chemistry in 1977 from the University of Arkansas.  He has also served as an officer in the USAF. [email: jharvey@northstarnm.com]

E. Philip Horwitz, Ph.D. - Senior Scientist

Dr. Horwitz is currently the Chief Scientific Officer of PG Research Foundation Inc. (PGRF), located in Darien, IL.  He has spent his entire career in the scientific arena of chemical separation technologies, with many of these spent in the specialized area of radioisotopes.  He worked for 38 years and retired the highest-ranking scientific officer at Argonne National Laboratory in Batavia, IL and is the holder of countless technology patents on the subject of chemical separations.   Dr. Horwitz awards include the 1984 Glenn T. Seaborg Actinide Separations Award, the 2000 American Chemical Society Award in Separation Science and Technology, and in 2004, the prestigious Becquerel Medal Award presented by the Royal Society of Chemistry in London.  As one of the inventors of the Licensed Technologies, Dr. Horwitz brings a level of expertise and enthusiasm not normally found with licensing technology.  His technology intellect, worldwide recognition, and relationships with Eichrom Technologies offer an extraordinary technology advantage to NorthStar Nuclear Medicine not available to its competition. [email: phorwitz@northstarnm.com]

Send mail to webmaster@northstarnm.com with questions or comments about this web site.
Copyright © 2005-2007 NorthStar Nuclear Medicine